{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:40:23Z","timestamp":1792474823946,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CVP"],"published-print":{"date-parts":[[2026,10,16]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Tumor angiogenesis contributes to tumor growth, metastasis, and treatment resistance, but\nthe newly formed vessels are often structurally abnormal and functionally inefficient. Antiangiogenic\ntherapy, particularly inhibition of Vascular Endothelial Growth Factor (VEGF) signaling,\nis now used in the treatment of multiple cancers. Its vascular effects depend strongly on the extent of\nangiogenic inhibition. Moderate inhibition may temporarily improve the structure and function of\nabnormal tumor vessels. This vascular normalization can improve perfusion, oxygenation, immune\ncell infiltration, and drug delivery in selected tumor types and treatment settings. More extensive\nvessel pruning can have the opposite effect, reducing perfusion, worsening hypoxia, and favoring\nadaptive resistance. VEGF inhibition also affects normal vessels because physiological angiogenic\nsignaling is required for endothelial homeostasis. Disruption of this signaling contributes to hypertension,\nthromboembolism, renal injury, cardiovascular complications, and cerebrovascular events. In\nthis narrative review, the mechanisms that shape tumor vascular remodeling and compare the vascular\neffects of anti-angiogenic and other vascular-modulating anticancer therapies in tumors and normal\ntissues are examined. Particular attention is given to the distinction between tumor-vessel normalization\nand vascular injury in normal tissues, as well as treatment scheduling, combination strategies,\ntargeted delivery, and vascular-response biomarkers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115701611508994261012075657","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:21:08Z","timestamp":1792473668000},"source":"Crossref","is-referenced-by-count":0,"title":["Anti-angiogenic Therapy at the Vascular Crossroads: Tumor Vessel Normalization, Excessive Pruning, and Systemic Vascular Toxicity"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3562-8545","authenticated-orcid":true,"given":"Jiahao","family":"Lu","sequence":"first","affiliation":[{"name":"School of Life Sciences, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3539-2497","authenticated-orcid":true,"given":"Junxiang","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0186-1793","authenticated-orcid":true,"given":"Yijin","family":"Chang","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-6544","authenticated-orcid":true,"given":"Dong","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-0781","authenticated-orcid":true,"given":"Changsheng","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611508994261012075657","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259598\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611508994261012075657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:21:14Z","timestamp":1792473674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259598\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701611508994261012075657","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}